Extract
In a recent issue of theEuropean Respiratory Journal, Bayet al。[1]报道了15例抗黑色素瘤相关蛋白5(抗MDA5+)迅速进行性间质肺疾病(RP-ild),需要体外生命支持(ECLS)。在五名患者中,ECLS的实施允许在中位延迟8天内进行紧急肺部移植桥,而在其他10例中,由于没有肺部移植,在没有肺部移植的情况下发生致命结果,要么在没有医疗移植的情况下清单进行移植。负责的团队或由于与潜在病因有关的取消资格。
Abstract
Life-threatening presentation of anti-MDA5+ rapidly progressive interstitial lung disease requires early specific diagnosis to implement extracorporeal life support as a bridge to lung transplantationhttps://bit.ly/3whd4ba
Footnotes
Conflict of interest: None declared.
- ReceivedApril 19, 2022.
- AcceptedApril 28, 2022.
- Copyright ©The authors 2022. For reproduction rights and permissions contactpermissions{at}ersnet.org
LIBRARY USERS
Log in through your institution
如果您的库有订阅,则可能已经通过IP地址登录。否则,您可能可以通过以下路线之一登录。
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password.To check if your institution is supported, please see此列表。Contact your library for more details.
If you think you should have access, please contact your librarian or emailjournals@ersnet.org
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.